Sponsors (4)
The bill centralizes and standardizes federal chronic-pain data and increases transparency—improving research, care, and policymaking—but raises privacy risks, potential costs to taxpayers, and the possibility of reduced industry participation or loss of clinical nuance.
People with chronic pain, clinicians, researchers, and policymakers will gain clearer national estimates and a centralized Chronic Pain Information Hub that improves visibility into the condition, makes federal evidence and tools easier to find, and supports better-informed care and policy decisions.
Researchers and clinicians will get standardized definitions and data-collection methods for population chronic-pain research, making studies more comparable and actionable across institutions.
Policymakers and Congress will receive an implementation report within two years, giving decisionmakers clearer evidence to target funding and programs to address gaps identified by the data.
Patients whose health data are included in aggregated claims and surveys risk re-identification or exposure of sensitive health information if deidentification is imperfect.
Taxpayers could face increased federal spending if Congress funds the hub and expanded data-collection activities for FY2026–2030.
Requiring public disclosure of manufacturer payments to collaborators could discourage some industry-funded researchers or partners from participating, reducing available data sources or expertise.
Based on analysis of 2 sections of legislative text.
Establishes a federal chronic pain information system and public hub to collect deidentified data, set research standards, publish disclosures, and report to Congress.
Official title: Advance population research for chronic pain.
Introduced July 21, 2026 by Timothy Michael Kaine · Last progress July 21, 2026
Creates a federally supported National Chronic Pain Information System that directs HHS, with CDC and NIH consultation, to compile and analyze deidentified research, claims, and survey data about chronic pain. It requires development of standard definitions and research approaches, public dissemination through a Chronic Pain Information Hub, disclosures of certain manufacturer payments to collaborators, and a report to Congress within two years. Authorizes appropriations for necessary sums for FY2026–2030 and defines chronic pain as persistent or recurrent pain lasting longer than three months.